Tradestie Institutional Equity Comparison Engine
UL vs CL โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CL Overall Edge
CL Captures Institutional Edge (3โ1 Pillars ยท 4โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Colgate-Palmolive Company (CL) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while UL counters with relative strength in Valuation. Fundamentally, UL trades at 18.5x Forward P/E with 20.0% operating margin (+0.5% YoY revenue) versus CL at 24.1x Forward P/E and 20.7% operating margin (+4.6% YoY). In options structure, UL sits in UNCLASSIFIED (13th %ile IV; Dealer Gamma Walls on Pro) against CL sits in SURGE (9th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
UL
UL 18.5x vs CL 24.1x Fwd P/E
Growth & Margin Winner
CL
Op Margin 20.0% vs 20.7% ยท YoY +0.5% vs +4.6%
Momentum & Technical Winner
CL
1Y +8.4% vs +25.8% ยท 52W Pos 45% vs 88%
Options & Structure Winner
CL
UNCLASSIFIED (13th %ile IV) vs SURGE (9th %ile IV)
UL
NYSE
Unilever plc
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
$63.82
+0.73% 1D
Market Cap
$136.4B
1M Return
-4.75%
1Y Return
+8.41%
Forward P/E
18.5x
Unified AI Score
46.7 / 100
HOLD
Tech 47.0
Fund 45.0
Flow 50.0
Mom 36.0
CL
NYSE
Colgate-Palmolive Company
Perfumes, Cosmetics & Other Toilet Preparations
$98.71
+1.89% 1D
Market Cap
$77.0B
1M Return
+1.36%
1Y Return
+25.79%
Forward P/E
24.1x
Unified AI Score
32.6 / 100
SELL
Tech 28.0
Fund 40.0
Flow 56.0
Mom 25.9
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
UL +8.41%
CL +25.79%
Spread: +17.38 pp (CL Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
UL TTM Op. Margin: 20.0%
CL TTM Op. Margin: 20.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UL vs CL. Trailing 12-month operating profitability (UL 20.0% vs CL 20.7%) and valuation multiples (UL 18.5x vs CL 24.1x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | UL | CL | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $136.4B | $77.0B | Larger Scale | UL |
| Trailing P/E Ratio Valuation | 13.0x | 38.4x | Lower Multiple | UL |
| Forward P/E Ratio Valuation | 18.5x | 24.1x | Lower Multiple | UL |
| Revenue Growth (YoY) Growth | +0.5% | +4.6% | Higher Growth | CL |
| Operating Margin (TTM) Profitability | 20.0% | 20.7% | Higher Margin | CL |
| Net Profit Margin Profitability | 18.3% | 9.7% | Higher Margin | UL |
| Return on Equity (ROE) Capital Efficiency | 31.9% | 231.7% | Higher ROE | CL |
| 52-Week Range Position Momentum | 45% ($55โ$75) | 88% ($76โ$102) | Stronger Trend | CL |
| Beta / 30D Volatility Risk Regime | -0.03ฮฒ ยท 24% Vol | -0.05ฮฒ ยท 28% Vol | Lower Realized Risk | UL |
| Unified Institutional Score Composite Signal | 46.7 / 100 (HOLD) | 32.6 / 100 (SELL) | Higher Composite | UL |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full UL vs CL Buy Guide
UL
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
13th %ile
IV Regime
Compressed (<25th %ile)
CL
SURGE
5d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
9th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither UL nor CL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.